PRICE T ROWE ASSOCIATES INC /MD/
Position in ORIC — Oric Pharmaceuticals, Inc.
CIK 80255
BALTIMORE, MD
Position in ORIC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$71,668,108
+$3,404,898 QoQ
Shares Held
6,617,554
+22.8% QoQ
Ownership
6.38%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#4
of 179 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ORIC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. ORIC ranks #58 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in ORIC
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $71,668,108 | 6,617,554 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $68,263,210 | 5,387,783 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $26,954,097 | 3,295,122 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $34,455,924 | 2,871,327 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $28,043,586 | 2,762,915 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,437,358 | 1,332,860 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $10,450,851 | 1,295,025 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $11,427,570 | 1,114,885 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,407,834 | 1,189,227 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $21,542,619 | 1,566,736 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,994,361 | 651,561 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $272,945 | 45,115 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $489,376 | 63,064 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $338,232 | 59,339 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $349,506 | 59,339 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $189,884 | 59,339 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $234,926 | 52,439 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $339,944 | 63,660 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $702,204 | 47,769 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||